Filing Details
- Accession Number:
- 0001477932-23-006094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-14 16:10:49
- Reporting Period:
- 2023-08-11
- Accepted Time:
- 2023-08-14 16:10:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1837607 | Aeon Biopharma Inc. | AEON | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557024 | Strathspey Crown Holdings Group, Llc | 4040 Macarthur Blvd. Suite 210 Newport Beach CA 92660 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-08-11 | 7,380,394 | $10.00 | 2,031,773 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reflects the disposition of shares of the Issuer's Class A Common Stock (the "Distributed Shares") by the Reporting Person in connection with the repurchase of certain of the Reporting Person's membership interests held by its members in exchange for, among other consideration, the Distributed Shares.
- In addition to the disposition of the Distributed Shares, the amount reflected includes a reduction in the Reporting Person's beneficial ownership by an additional 8,203 shares of the Issuer's Class A Common Stock to correct an inadvertent overstatement of such ownership by such amount in the Reporting Person's Form 3 filed with the Securities and Exchange Commission on July 31, 2023.